Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.
By R. Ramasamy, S. Vannucci, Shirley Shidu Yan, K. Herold, S. Yan, A. Schmidt. Glycobiology, 2005
810 citations recorded by the source corpus.
Subfields: Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Neurology
View Paper: https://www.semanticscholar.org/paper/3b86ab12c3de399eac15a1e9bc6f4be49e65bd2d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
Citations in the corpus
- Diabetic macular edema: pathogenesis and treatment. (2009, background): “Animal studies have shown AGEs to be involved in activation of all these processes.(183,233,276)”
- Periodontal disease: associations with diabetes, glycemic control and complications. (2008, background): “These cell types include mononuclear phagocytes , endothelial cells, fibroblasts, smooth muscle cells, lymphocytes, podocytes, and neurons (Brett et al, 1993; Ramasamy et al, 2005).”
- Oxidative Stress in Aging Human Skin (2015, background): “Unfortunately though the decreased activity of this enzyme has been reported during aging [281].”
- Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives (2022, background): “The increased ER stress will cause mitochondrial dysfunction, alter redox homeostasis, play a crucial role in damaging cellular processes and the infrastructure of the cell, and contribute to oxidative stress propagation [2,69,70].”
- Polyphenols and Human Health: Prevention of Disease and Mechanisms of Action (2010, background): “be capable of reducing the neurodegeneration associated with the accumulation AGEs during normal [203] and abnormal brain ageing [204].”